Revenue
attach_money294M USD
YoY +64.1%
RIGLRigel Pharmaceuticals, Inc.$ --
Rigel Pharmaceuticals, Inc.
RIGL
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart125M USD
YoY +418.6%
Net Income
verified367M USD
YoY +1999.1%
EPS
pie_chart20.4USD
YoY +1960.6%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress292.8%On Track
Revenue Progress294.3M
Revenue Forecast293.2M
Net Income Progress367M
Net Income Forecast125.3M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.